help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 25, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1653
A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/1/64    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burnett, M. S.
Right arrow Articles by Howard, B. V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burnett, M. S.
Right arrow Articles by Howard, B. V

Submitted on July 26, 2005
Accepted on October 13, 2005

Cross Sectional Associations of Resistin, Coronary Heart Disease and Insulin Resistance

Mary Susan Burnett PhD*, Joseph M. Devaney PhD, Remi J. Adenika BS, Robert Lindsay MD, and Barbara V Howard PhD

MedStar Research Institute, Washington, DC Children's National Medical Center, Washington, DC BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom G116NT

* To whom correspondence should be addressed. E-mail: Mary.s.burnett-miller{at}medstar.net.

Context. Recently, resistin was found to be present in atherosclerotic lesions in apoE - mice. Resistin may be associated with inflammation and atherosclerosis in humans; however the role of resistin in human disease remains controversial.

Objective. To assess cross-sectional relationships of resistin with coronary heart disease (CHD).

Design, Setting and Participants. Blood samples from the third examination of the Strong Heart Study (SHS)- the largest study of CHD in American Indians were used. Cases- who had suffered previous myocardial infarction (MI) (n = 100)- were selected randomly from the three SHS sites and matched for study site and sex with controls who had no history of CVD (n = 100).

Main Outcome Measure: Coronary heart disease

Results. Resistin levels were higher in cases than controls (median [interquartile range]: 3.4 [2.5-4.7] vs. 2.8 [2.1-4.0] ng/mL, P = 0.003) and had univariate correlations with age (Spearman r=0.21, P < 0.002), fasting insulin (r=0.21, P = 0.003), insulin resistance by homeostasis model (r=0.22; P = 0.04), albumin:creatinine ratio (ACR: r=0.19, P = 0.01) and fibrinogen (r=0.34, P < 0.0001). Cases were more likely to have diabetes (Cases 67%; Controls 41%; P < 0.0001) but had similar BMI (Cases 31.4 ± 5.4; Controls 30.7 ± 6.3; P = 0.85). Resistin levels were higher in participants with established nephropathy (ACR>300 mg/g n = 26) compared with those with normo- (n = 122) or micro-albuminuria (n = 42: Figure). In multivariate analysis nephropathy (P = 0.0013) but not previous MI (P = 0.12) was significantly associated with resistin.

Conclusions. Resistin is not independently associated with CHD. Resistin is elevated in survivors of MI; however, this reflects a novel association of raised resistin with diabetic nephropathy.


Key words: resistin • the Strong Heart Study • cardiovascular disease




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Weikert, S. Westphal, K. Berger, J. Dierkes, M. Mohlig, J. Spranger, E. B. Rimm, S. N. Willich, H. Boeing, and T. Pischon
Plasma Resistin Levels and Risk of Myocardial Infarction and Ischemic Stroke
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2647 - 2653.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. T. Gentile, C. Vecchione, G. Marino, A. Aretini, A. Di Pardo, G. Antenucci, A. Maffei, G. Cifelli, L. Iorio, A. Landolfi, et al.
Resistin Impairs Insulin-Evoked Vasodilation
Diabetes, March 1, 2008; 57(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ellington, A. R. Malik, G. G. Klee, and I. J. Kullo
Response to Resistin, Glomerular Filtration Rate, and Insulin Resistance
Hypertension, February 1, 2008; 51(2): e12 - e12.
[Full Text] [PDF]


Home page
CirculationHome page
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman
Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study
Circulation, November 13, 2007; 116(20): 2275 - 2279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ellington, A. R. Malik, G. G. Klee, S. T. Turner, A. D. Rule, T. H. Mosley Jr, and I. J. Kullo
Association of Plasma Resistin With Glomerular Filtration Rate and Albuminuria in Hypertensive Adults
Hypertension, October 1, 2007; 50(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
N. Pischon, N. Heng, J.-P. Bernimoulin, B.-M. Kleber, S.N. Willich, and T. Pischon
Obesity, Inflammation, and Periodontal Disease
J. Dent. Res., May 1, 2007; 86(5): 400 - 409.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G D Norata, M Ongari, K Garlaschelli, S Raselli, L Grigore, and A L Catapano
Plasma resistin levels correlate with determinants of the metabolic syndrome
Eur. J. Endocrinol., February 1, 2007; 156(2): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. V. Silha, B.L. G. Nyomba, W. D. Leslie, and L. J. Murphy
Ethnicity, Insulin Resistance, and Inflammatory Adipokines in Women at High and Low Risk for Vascular Disease
Diabetes Care, February 1, 2007; 30(2): 286 - 291.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society